XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Compensation Plans
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Plans
12.
Share-Based Compensation Plans

 

Share Incentive Plan

 

On June 14, 2023, the Company’s Shareholders approved the Global Indemnity Group, LLC 2023 Share Incentive Plan (“the 2023 Plan”). The primary purpose of the 2023 Plan is to provide Global Indemnity a competitive advantage in attracting, retaining, and motivating officers, employees, consultants and non-employee directors, and to position Global Indemnity to offer incentives linked to the financial results of the Company’s business and increases in shareholder value. Under the 2023 Plan, the Company may issue up to 2.5 million class A common shares pursuant to awards granted under the Plan. The 2023 Plan replaced the Global Indemnity Group, LLC 2018 Share Incentive Plan, as amended and restated on August 28, 2020 which expired pursuant to its terms on March 4, 2023.

Options

No stock options were awarded during the quarters and six months ended June 30, 2023 or 2022. No unvested stock options were forfeited during the quarters and six months ended June 30, 2023 or 2022.

Restricted Shares / Restricted Stock Units

There were no restricted class A common shares or restricted stock units granted to key employees during the quarters and six months ended June 30, 2023 and 2022. There were no restricted class A common shares or restricted stock units forfeited during the quarter and six months ended June 30, 2023 and 2022.

There were 49,628 and 35,442 restricted stock units that vested during the quarters ended June 30, 2023 and 2022, respectively, and 75,541 and 61,522 restricted stock units that vested during the six months ended June 30, 2023 and 2022, respectively Upon vesting, the restricted stock units converted to restricted class A common shares.

During the quarters ended June 30, 2023 and 2022, the Company granted 22,279 and 25,760 class A common shares, respectively, at a weighted average grant date value of $30.20 and $25.96 per share, respectively, to non-employee directors of the Company under the Plan. During the six months ended June 30, 2023 and 2022, the Company granted 48,705 and 50,570 class A common shares, respectively, at a weighted average grant date value of $27.63 and $25.80 per share, respectively, to non-employee directors of the Company under the Plan. The Company previously granted 157,139 shares to a non-employee director with deferred vesting. These shares vested on January 13, 2023. All other shares granted to non-employee directors of the Company are fully vested but are subject to certain restrictions.

Rule 10b5-1 Trading Plans

The Company did not have any Rule 10b5-1 Trading Plans in place during the six months ended June 30, 2023 and 2022.